# Betamethasone and Severity of Hyaline Membrane Disease

> **NCT01854840** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 127 (actual)

## Conditions studied

- Pregnant Women Receive Celesten

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01854840
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-12
- **Primary completion:** 2017-06-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854840, "Betamethasone and Severity of Hyaline Membrane Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01854840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*